Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse
Clinical trial NCT05480046 · COMPLETED
Trial details
- NCT number
- NCT05480046
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-18
- Primary completion
- 2025-03-13
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.